Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BroadOak Capital Partners

BroadOak Capital Partners?uq=UG6efJS6
OTHER INVESTOR TYPE
Active STATUS
7 PROFESSIONALS
29 INVESTMENTS
13 PORTFOLIO
16 EXITS
Description

BroadOak Capital Partners is an investment bank that is also involved in growth equity, venture capital and mezzanine investments. The firm focuses on the life sciences industry, research tool and consumable, diagnostic, therapeutic and biotechnology sectors. The firm also provides banking and financial advisory services to corporate and institutional clients. It was founded on 2006 and is headquartered in Bethesda, Maryland.

Investor Status
Actively Seeking New Investments
Year Founded
2006
Primary Investor Type
Investment Bank
Other Investor Types
Growth/Expansion
Mezzanine
PE/Buyout
Venture Capital
Primary Office
  • 4800 Montgomery Lane
  • Suite 230
  • Bethesda, MD 20814
  • United States

+1 (301) 000-0000

BroadOak Capital Partners Investments (29)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
BioInformatics 05-Mar-2018 Later Stage VC 0000 Consulting Services (B2B) Generating Revenue 0000000 000000
00000000 01-Jun-2017 00 000000000 Biotechnology Generating Revenue
0000000000 01-Jun-2017 00 000000000 000.00 Laboratory Services (Healthcare) Profitable 0000000 0000000
0000 0000 01-May-2017 00 000000000 Diagnostic Equipment Generating Revenue
00000 (000) 01-Mar-2017 00 000000000 Drug Discovery Generating Revenue
0000000000-000000. 21-Oct-2016 00000 00000 Social/Platform Software Generating Revenue
000000 00000000 20-May-2016 00000 00000 00.000 Drug Discovery Generating Revenue 0000000 000000
0000 000000000000 05-Nov-2015 00000 00000 00.000 Therapeutic Devices Generating Revenue
Diagnostic BioSystems 11-May-2015 PE Growth/Expansion Biotechnology Generating Revenue 0000000 000000
Empire Genomics 14-Nov-2014 Seed Round 00.00 Drug Discovery Generating Revenue 0000000 000000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BroadOak Capital Partners’s full profile, request a free trial.

BroadOak Capital Partners Exits (16)

Company Name Exit Date Exit Type Exit Size Status Buyers
Gold Standard Diagnostics 06-Jul-2018 Merger/Acquisition Completed
  • Eurofins
0000 000000000000 07-Jun-2018 000000000000000000 Completed
  • 000-000000
000000000 23-May-2018 000000000000000000 Completed
  • 000000 000
0000000 00000000 17-Jan-2017 000000000000000000 0000 Completed
  • 000000 000 000
0000 000 29-Nov-2016 000000000000000000 0000 Completed
  • 000000 0000000000
0000000 00000000 0 15-Jan-2015 000000000000000000 Completed
00000 28-May-2014 000000000000000000 0000 Completed
  • 0000000
000000 0000000000 29-Jan-2014 000000000000000000 Completed
  • 000 000
Smithers Avanza 01-Dec-2012 Merger/Acquisition Completed
  • The Smithers Group
Selah Genomics 31-Dec-2009 Merger/Acquisition Completed
To view this investor’s complete exits history, request access »

BroadOak Capital Partners Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is reserved for PitchBook Platform accredited users. To explore BroadOak Capital Partners‘s full profile, request access.

Request full access to PitchBook

BroadOak Capital Partners Team (12)

Name Title Deals Funds Boards Office Contact
Info
Lars Hanan Co-Founder & Partner 0 0 Bethesda, MD
William Snider Co-Founder & Partner 0 0 0 Bethesda, MD
D. Kyle Wilson Partner 0 0 Bethesda, MD
Timothy Johnson Partner 0 0 Bethesda, MD
Matthew McFarland Vice President Bethesda, MD

5 Former Team Members

You’re viewing 5 of 12 team members. Get the full list »